DNA Option Overview

Ginkgo Bioworks Holdings Inc (DNA) options traded 1.36K contracts on Nov 4, 2026, below the 20-day average of 2.16K, and calls outnumber puts. 30-day implied volatility was 122.1%, in the lower part of its one-year range. Near-term max pain was $10.04, 13.9% below the $11.66 close.

About DNA

DNA Options FAQ

How actively are DNA options traded?

1.09K calls and 268 puts traded on Nov 4, 2026, 1.36K contracts in total. Open interest was 65.64K contracts. Over the past 30 days, volume averaged 3.38K contracts per day. The DNA option volume chart shows volume by strike and expiration date.

Is DNA implied volatility high right now?

Ginkgo Bioworks IV rank is 29, so its 30-day implied volatility of 122.1% is in the lower part of its one-year range. Over the past year it ranged from 77.1% on Aug 18, 2026 to 230.6% on Jul 17, 2026. See the DNA implied volatility history for a longer view.

What is the DNA put/call ratio?

The Ginkgo Bioworks put/call volume ratio was 0.25 on Nov 4, 2026, so calls outnumber puts. The put/call open interest ratio was 0.11. The DNA open interest chart shows calls and puts at each strike.

What is DNA max pain this week?

As of the Nov 4, 2026 close, max pain for Ginkgo Bioworks options about one week from expiration was $10.04, 13.9% below the $11.66 close. The DNA max pain chart shows it for every expiration date.

What is DNA's expected move over the next week?

Based on 7-day implied volatility of 133.3%, options price a move of about ±$2.15 (±18.5%) over the next week, a range of roughly $9.51 to $13.81 from the Nov 4, 2026 close. The DNA expected move chart shows it for every expiration date.